Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.20.2
Consolidated Balance Sheets - USD ($)
Mar. 31, 2020
Mar. 31, 2019
Current    
Cash and cash equivalents $ 2,269,747 $ 446,779
Accounts receivable, net of allowance for doubtful accounts of $167,500 (March 31, 2019 - $Nil) 846,964 1,523,193
Prepaid expenses and other receivables (Note 5) 1,632,555 1,355,032
Inventories (Note 6) 1,059,462 405,682
Due from related parties (Note 9(a)) 17,840 18,585
Total Current Assets 5,826,568 3,749,271
Equipment (Note 7) 154,144 192,528
Technology and other assets (Note 4) 1,449,924 4,427,722
Goodwill (Note 3) 11,085,984 22,308,275
Total Assets 18,516,620 30,677,796
Current    
Accounts Payable (Notes 9(b)) 857,093 1,148,852
Accrued liabilities (Notes 8 and 9(b)) 1,647,656 1,653,233
Demand loans (Note 8) 2,078,833 0
Deferred revenue - Contract Liabilities 616,063 467,778
Total Current Liabilities 5,199,645 3,269,863
Shareholders' Equity    
Preferred Stock, par value $0.001; Authorized 10,000,000 Special Voting Preferred Stock, par value $0.001; Authorized; Issued and outstanding - 1 (March 31, 2019 - 1)
Common Shares, par value $0.001; Authorized - 500,000,000; Issued and outstanding 5,009,151 and 117,683 Exchangeable Shares (March 31, 2019 - 3,661,838 and 196,799 Exchangeable Shares) 5,126 3,858
Additional paid in capital 84,643,570 73,719,299
Deficit (71,373,870) (46,357,373)
Accumulated other comprehensive income 42,149 42,149
Total Shareholders' Equity 13,316,975 27,407,933
Total Liabilities and Shareholders' Equity $ 18,516,620 $ 30,677,796